Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 16 » default
ESCI
Impact Factor
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (188)
- Volume 16, 2024 (3)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 16, 2024
Case report
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
Bu Y, Wen J, Wang F, Dong S, He L, Li Y, Liang J, Zhang H
Hepatic Medicine: Evidence and Research 2024, 16:31-36
Published Date: 20 April 2024
Review
Chimeric Livers: Interspecies Blastocyst Complementation and Xenotransplantation for End-Stage Liver Disease
Blake MJ, Steer CJ
Hepatic Medicine: Evidence and Research 2024, 16:11-29
Published Date: 16 February 2024
Original Research
The Free Triiodothyronine, Gamma-Glutamyl Transpeptidase and Spontaneous Bacterial Peritonitis Index: A Novel Model for Predicting 1-Year Mortality in Patients with HBV-Related Hepatic Encephalopathy
Lin L, Huang ZY, Liu K, Tong XC, Zhang ZX, Xue Y
Hepatic Medicine: Evidence and Research 2024, 16:1-9
Published Date: 22 January 2024